search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
TEXTURES 165


Formulation 2: Powder-to-Foam Facial Wash S0202 Phase Trade Name (Supplier)


INCI


A Kukui nut oil (Aroma Zone) Pureact SCG (Innospec)


Aleurites Moluccanus Seed Oil Sodium Cocoyl Glycinate


Fleurs du Paradis (Aroma zone) Parfum - – - –


- –


Pureact I-78 (Innospec) Pureact WSP (Innospec)


SunShine Glitter White (Sun Chemical)


SunShine Super Raspberry (Sun Chemical)


Kaolin


Sodium Cocoyl Isethionate Sodium Methyl Cocoyl Taurate


Synthetic Fluorphlogopite Synthetic Fluorphlogopite


Prototype formulation Powder-to-Foam Facial Wash S0202 (Formulation 2) is an innovative powder format that is, cold processed, water-free, sulfate-free and produces a dense, soft, creamy foam.


Light and fresh textures Products that offer a light, fresh texture without compromising on an effective result can sometimes be difficult to formulate. In today’s market, formulators look for products that are light, easy to apply and can still provide that sought-after performance. By carefully selecting ingredients, a


Phase Trade Name (Supplier)


A Empilan® (Innospec)


DPHS


Coconut oil (Aroma Zone)


Finsolv® TPP (Innospec) Activemol


Sorbitol Allantoin


%


5.0 5.0 q.s. 5.0 2.0


q.s. to 100


12.5 17.5


2.0 2.0


Powder-to-Foam Facial Wash S0202


formulation can have the right texture to provide that desired sensory appeal along with effective cleansing and moisturising results.


Light and fresh ingredients Maritech®


Bright is a marine extract (Fucus


Vesiculosus Extract) combining the skin brightening and antioxidant effects of fucoidan and marine polyphenols. It is safe, non-sensitising and highly effective at brightening skin. It enhances radiance and visibly reduces age spot pigmentation. Central to the efficacy of this ingredient is its


Formulation 3: Light years Away Serum S0199 INCI


PEG-30 Dipolyhydroxystearate


Cocos Nucifera Oil


C12-15 Alkyl Benzoate (and) Dipropylene Glycol Dibenzoate (and) PPG-15 Stearyl Ether Benzoate


DOM-R (Innospec) Diethylhexyl Maleate Volasil®


DM 1.5 (Innospec)


Ester 610 (Mosselman)


B Aqua


Carbopol Ultrez 21 Polymer (Lubrizol)


Maritech® (Innospec)


Light years


Away Serum S0199


Bright


SunCROMA D&C Red 30 Talc (Sun Chemical)


Microcare PHG (Thor)


Pomme d’Happy (Aroma Zone)


April 2019 Dimethicone


Caprylic/Capric Triglycerides


% 1.5 2.0 5.0 1.0 5.0 3.6


Up to 100


Acrylates/C10-30 Alkyl Acrylate Crosspolymer 0.8


Fucus Vesiculus Extract 0.3 CI73360


Caprylyl Glycol (and) Phenoxyethanol


Perfume 0.1 0.1 0.8 PERSONAL CARE EUROPE


proven ability to inhibit elastase, collagenase and tyrosinase – key enzymes known to accelerate the visible signs of ageing. Finsolv TPP exhibits excellent tactile and


performance improvements over the individual materials that comprise it. The C12-15 alkyl benzoate moiety exhibits a soft, smooth, non- greasy rub in while the dipropylene glycol dibenzoate adds an occlusive property and the PPG-15 stearyl ether benzoate helps in coupling the three esters.


This unique blend of emolliency and occlusiveness combine to produce a moisturizer with superior tactile and performance properties. In a side-by-side corneometer study, TPP provides similar moisturisation benefits over 6 hours as petrolatum but while imparting a dry, non- greasy and cosmetically elegant emollient feel. Activemol®


DOM-R is a light, water white


lipophilic ester which exhibits high performance properties in both skin care and hair care formulations. This unique diester provides excellent solubility properties while also offering moisturisation benefits to skin and hair. Volasil®


DM 1.5 is a linear low molecular


weight silicone and finds uses where volatility is key without cyclic silicones.


Prototype formulation Light Years Away Serum S0199 (Formulation 3)


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184  |  Page 185  |  Page 186  |  Page 187  |  Page 188